Stanley Furniture Enters Into Rights Agreement To Protect

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Stanley Furniture Enters Into Rights Agreement To Protect Net Operating Losses

HIGH POINT, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Stanley Furniture Company, Inc. (Nasdaq: STLY ) (the “Company”) announced today that its Board of Directors (the “Board”) has adopted a Rights Agreement (the “Rights Agreement”) designed to protect the company’s substantial net operating loss carryforwards (“NOLs”).  As of October 1, 2016, the Company had approximately $20.4 million in NOLs, which can be used, in certain circumstances, to offset future taxable income for U.S. federal income tax purposes. 

The Rights Agreement is intended to preserve and protect the value of the Company’s NOLs by deterring an “ownership change” within the meaning of Section 382 of the Internal Revenue Code that could lead to the loss of the Company’s NOLs and a resulting reduction in the Company’s value.  In general, an ownership change would occur if one or more stockholders owning 5% or more of the Company’s common stock were to increase their cumulative ownership of Company common stock by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period.  These provisions can be triggered not only by merger and acquisition activity but by trading as well. 

The Board adopted the Rights Agreement after considering, among other matters, the estimated value of the tax benefits of the NOLs, the potential for the tax benefits to decrease in value upon an ownership change and the risk of an ownership change occurring.  The Company believes that no ownership change as defined in Section 382 has occurred as of the date of this press release that would impair its current NOLs.

Under the Rights Agreement, Company stockholders of record as of December 15, 2016 will receive one preferred share purchase right for each share of common stock they own on such date.  If a person or group acquires beneficial ownership of 4.9% or more of the Company’s outstanding common stock (subject to certain specified exceptions), the rights will become exercisable.  The rights will also become exercisable if a person or group that already owns 4.9% or more of the Company’s outstanding common stock acquires an additional 1% or more of the Company’s outstanding common stock.  If the rights become exercisable, all holders of rights, other than the person or group triggering the rights, will be entitled to purchase Company common stock at a 50% discount.  Rights held by the person or group triggering the rights will become void and will not be exercisable.

The rights will trade with the Company’s common stock and Company stockholders do not need to take any action to receive their rights.  The Rights Agreement and the rights will expire on the first day after the Company’s 2017 annual meeting of stockholders unless the Company’s stockholders approve the Rights Agreement at the meeting, in which case the Rights Agreement and the rights will expire on December 5, 2019 (unless the Company’s NOLs are utilized prior to that date).  The Board may amend the Rights Agreement in any way or redeem the rights at any time unless and until the rights are triggered.

The Rights Agreement includes a procedure for the Board to consider requests to exempt a particular transaction from triggering the exercisability of the rights under the Rights Agreement if the transaction (i) does not (x) create a significant risk of the Company’s NOLs being impaired or (y) constitute a default under the change-in-control covenant included in the Company’s credit facility or (ii) is otherwise in the best interests of the Company.

Additional information with respect to the Rights Agreement will be included in a Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission.

Review of Strategic Opportunities

In June 2016, the Company announced that its Board engaged Stephens Inc. as financial advisor in connection with the consideration of potential strategic and capital allocation opportunities.  In connection with the announcement of the adoption of the Rights Agreement, the Company indicated that this strategic review is ongoing, including consideration of a possible sale, merger or other business combination involving the Company.   The Company has not made a decision to pursue any particular transaction, and there can be no assurance that the consideration of potential alternatives will result in any transaction being pursued or completed.  The Company has not set a timetable for completion of the consideration process, and it does not expect to comment further unless and until the Board has approved a specific transaction, or it otherwise deems further disclosure appropriate or required by law.

About Stanley Furniture Company, Inc.

Established in 1924, Stanley Furniture Company, Inc. is a leading design, marketing and overseas sourcing resource in the middle-to-upscale segment of the wood residential market. The Company offers a diversified product line supported by an overseas sourcing model and markets its brands through the wholesale trade’s network of brick-and-mortar furniture retailers, online retailers and interior designers worldwide, as well as through direct sales to the consumer through a localized approach to ecommerce fulfillment.  The Company’s common stock is traded on the NASDAQ stock market under the symbol STLY.

Stanley Furniture Company, Inc. Investor Contact: Anita W. Wimmer (336) 884-7698

Scroll down for more posts ▼

Top 10 Most Recent News Articles

XiamenAir Takes Off with Fujian-London Link

Updated Category News Views 1

A New Dawn for Fujian Travelers Here's a nugget to chew on: XiamenAir's first-ever direct flight from Xiamen to London had its moment in the spotlight. This isn't just another intercontinental flyby—it's a game-changer for folks in Fujian looking to hop across the pond without the layover hassle. With Flight MF821 touching down in Heathrow early on September 6th, this...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 3

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 1

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading

Top 5 Most Recently Viewed Articles

Archer Aviation's Q4 Earnings Report: Key Insights and Future Plans

Updated Category News Views 344

Archer Aviation Reports Q4 Earnings and Future Plans Archer Aviation Inc (ACHR) has recently disclosed its financial results for the fourth quarter of the fiscal year. This report provides an in-depth look at crucial details associated with their recent earnings and future strategies. Understanding Archer's Q4 Financial Performance During the fourth quarter, Archer...

Continue Reading
Alvotech's Progress on FDA Review for AVT05 Biosimilar

Updated Category News Views 265

Alvotech's Update on AVT05 Biologics License Application Alvotech (NASDAQ: ALVO), a prominent global biotech firm dedicated to crafting biosimilar medicines, recently announced significant developments regarding its Biologics License Application (BLA) for AVT05. This biosimilar candidate, designed to imitate Simponi (golimumab), is being presented in both prefilled...

Continue Reading
Benzinga Honors Fintech Innovators at Capital Conference 2025

Updated Category News Views 199

Benzinga Celebrates the Best in Fintech Innovations Benzinga, a standout leader in financial media and data, held an extraordinary event celebrating the annual Fintech Awards. The event recognized remarkable achievements shaping the future of the financial sector, inspiring executives and innovators alike. A Night of Glorious Recognition The awards ceremony was a...

Continue Reading
Understanding the Decline in Eastern Bankshares Short Interest

Updated Category News Views 107

Overview of Eastern Bankshares Short Interest Eastern Bankshares EBC has witnessed a reduction in its short interest, which is a metric used by investors to gauge market sentiment. Recently, the short percent of float dropped by 3.96%. The company reported approximately 4.26 million shares sold short, equating to about 2.18% of all shares available for trading. Given its...

Continue Reading
Promising Results from enGene's Bladder Cancer Trial Excite Investors

Updated Category News Views 121

Excitement in the Air for enGene Holdings Inc. enGene Holdings Inc. (NASDAQ: ENGN) is experiencing a significant surge in its stock price as more promising data emerges from its ongoing clinical trials. As of the latest reporting period, the company's stock surged higher, showcasing a remarkable increase. This positive upward momentum coincides with the release of the new...

Continue Reading